Literature DB >> 33686724

Judging a Fish by Its Ability to Climb a Tree? A Call for Novel Endpoints in the Appraisal of Ablative Local Treatments of Oligometastatic Cancer.

Mauro Loi1, Marco Alifano2, Marta Scorsetti3,4, Joost J Nuyttens5, Lorenzo Livi1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33686724      PMCID： PMC8176969          DOI： 10.1002/onco.13747

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  9 in total

Review 1.  (Oligo)metastasis as a Spectrum of Disease.

Authors:  Stanley I Gutiontov; Sean P Pitroda; Phuoc T Tran; Ralph R Weichselbaum
Journal:  Cancer Res       Date:  2021-01-15       Impact factor: 12.701

2.  Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer.

Authors:  I Desideri; G Francolini; V Scotti; D Pezzulla; C Becherini; F Terziani; C Delli Paoli; E Olmetto; L Visani; I Meattini; D Greto; P Bonomo; M Loi; B Detti; L Livi
Journal:  Clin Transl Oncol       Date:  2018-12-18       Impact factor: 3.405

3.  Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study.

Authors:  Joost J Nuyttens; Noëlle C M G van der Voort van Zyp; Cornelis Verhoef; A Maat; Robertus J van Klaveren; Bronno van der Holt; Joachim Aerts; Mischa Hoogeman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-02-01       Impact factor: 7.038

4.  Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent.

Authors:  Michela Buglione; Barbara Alicja Jereczek-Fossa; Marco Lorenzo Bonù; Davide Franceschini; Andrei Fodor; Isa Bossi Zanetti; Marianna Alessandra Gerardi; Paolo Borghetti; Davide Tomasini; Nadia Gisella Di Muzio; Olga Oneta; Marta Scorsetti; Ciro Franzese; Paola Romanelli; Giampiero Catalano; Italo Dell'Oca; Giancarlo Beltramo; Giovanni Battista Ivaldi; Antonio Laudati; Stefano Maria Magrini; Paolo Antognoni
Journal:  Lung Cancer       Date:  2020-01-03       Impact factor: 5.705

5.  Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockade.

Authors:  Kunal K Sindhu; Amanda Leiter; Erin Moshier; Jung-Yi Lin; Emily Carroll; Danielle Brooks; Jennifer Ben Shimol; Elliot Eisenberg; Emily J Gallagher; Richard G Stock; Matthew D Galsky; Michael Buckstein
Journal:  Cancer Treat Res Commun       Date:  2020-10-08

6.  Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis.

Authors:  Kyle E Rusthoven; Susan F Hammerman; Brian D Kavanagh; Michael J Birtwhistle; Mark Stares; D Ross Camidge
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

7.  Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma.

Authors:  Nicholas D Klemen; Melinda Wang; Paul L Feingold; Kirsten Cooper; Sabrina N Pavri; Dale Han; Frank C Detterbeck; Daniel J Boffa; Sajid A Khan; Kelly Olino; James Clune; Stephan Ariyan; Ronald R Salem; Sarah A Weiss; Harriet M Kluger; Mario Sznol; Charles Cha
Journal:  J Immunother Cancer       Date:  2019-07-24       Impact factor: 13.751

8.  Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis.

Authors:  Ian Poon; Darby Erler; Roi Dagan; Kristin J Redmond; Matthew Foote; Serena Badellino; Tithi Biswas; Alexander V Louie; Young Lee; Eshetu G Atenafu; Umberto Ricardi; Arjun Sahgal
Journal:  JAMA Netw Open       Date:  2020-11-02

9.  Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial.

Authors:  David A Palma; Robert Olson; Stephen Harrow; Stewart Gaede; Alexander V Louie; Cornelis Haasbeek; Liam Mulroy; Michael Lock; George B Rodrigues; Brian P Yaremko; Devin Schellenberg; Belal Ahmad; Sashendra Senthi; Anand Swaminath; Neil Kopek; Mitchell Liu; Karen Moore; Suzanne Currie; Roel Schlijper; Glenn S Bauman; Joanna Laba; X Melody Qu; Andrew Warner; Suresh Senan
Journal:  J Clin Oncol       Date:  2020-06-02       Impact factor: 44.544
  9 in total
  1 in total

Review 1.  A critical review on oligometastatic disease: a radiation oncologist's perspective.

Authors:  Pietro Pacifico; Riccardo Ray Colciago; Francesca De Felice; Luca Boldrini; Viola Salvestrini; Valerio Nardone; Isacco Desideri; Carlo Greco; Stefano Arcangeli
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.